CD37 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD37 monoclonal antibodies for research focused on understanding immune regulation mechanisms. CD37 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD37 is a tetraspanin protein that plays a crucial role in the regulation of immune responses, particularly in B cells and T cells. CD37 functions in cell signaling, adhesion, and the modulation of immune cell interactions, making it a significant target for studies related to immunology and cancer research. Understanding CD37 expression and activity can provide insights into various diseases, including lymphomas and leukemias, where expression patterns are often altered. CD37 monoclonal antibodies enable detailed investigation of cellular pathways and molecular mechanisms in immune system function. Researchers can utilize CD37 monoclonal antibodies to examine protein localization, expression levels, and interactions with other molecules. CD37 monoclonal antibodies from Santa Cruz Biotechnology support the scientific community in advancing our understanding of immune system regulation and potential therapeutic approaches.